Modafinil Induced Psychosis in a Patient with Recurrent Depressive Disorder: A Case Report

Authors

DOI:

https://doi.org/10.30834/KJP.39.1.2026.541

Keywords:

Modafinil, Depressive Disorder, Medication Induced Psychosis, Drug Monitoring

Abstract

BACKGROUND: Modafinil is the first FDA-designated “wakefulness-promoting agent” and is approved for use as an adjuvant in mood disorders. In depressive disorders, it is reported to be effective in alleviating fatigue and related symptoms. The molecule is widely used today.  Since it belongs to the group of stimulants, theoretically, it can cause psychosis.

CASE REPORT: We report the case of a 48-year-old woman with recurrent depressive disorder who developed psychotic symptoms, including visual and auditory hallucinations, within two days of initiating modafinil (100 mg/day) for fatigue. Symptoms worsened following venlafaxine addition but entirely resolved within five days of modafinil discontinuation, with no recurrence over six months.

CONCLUSION: This case highlights the risk of modafinil-induced psychosis, even at standard doses, and suggests a possible interaction with venlafaxine. Clinicians should monitor for psychotic symptoms in vulnerable patients, warranting further investigation into modafinil’s neurobiological effects.

Downloads

Download data is not yet available.

References

Keramatian K, Chithra NK, Yatham LN. The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. Focus (Am Psychiatr Publ). 2023 Oct; 21(4):344-353. DOI: 10.1176/appi.focus.20230009

Aytas O, Dilek Yalvac H. Modafinil-Induced Psychosis: A Case Report. Noro Psikiyatr Ars. 2015 Mar; 52(1):99-101. DOI: 10.5152/npa.2015.7160

Jacob MK, Ash P. Venlafaxine-induced complex visual hallucinations in a 17-year-old boy. J Clin Psychiatry. 2009 Apr; 70(4):601-3. DOI: 10.4088/jcp.08l04627

DiSciullo AA, English CD, Horn WT. Modafinil Induced Psychosis in a Patient with Bipolar 1 Depression. Case Rep Psychiatry. 2018 Oct 17; 2018:3732958. DOI: 10.1155/2018/3732958

Wu P, Jones S, Ryan CJ, Michail D, Robinson TD. Modafinil-induced psychosis. Intern Med J. 2008 Aug; 38(8):677-8. DOI: 10.1111/j.1445-5994.2008.01710.x

Flavell J. Modafinil-induced psychosis in a patient with attention deficit hyperactivity disorder. Australas Psychiatry. 2021 Jun; 29(3):366-67. DOI: 10.1177/1039856220936630

Wisor J. Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions. Front Neurol. 2013 Oct 7; 4:139. DOI: 10.3389/fneur.2013.00139

Boland R, Verduin ML. Kaplan and Sadock’s Comprehensive Text of Psychiatry. Lippincott Williams & Wilkins; 2024. ISBN/ISSN:9781975175733

Downloads

Published

24-02-2026

How to Cite

Gopika SS, Diya P Albert, and Vidhukumar Karunakaran. “Modafinil Induced Psychosis in a Patient With Recurrent Depressive Disorder: A Case Report”. Kerala Journal of Psychiatry, Feb. 2026, doi:10.30834/KJP.39.1.2026.541.

Issue

Section

Case Report